CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Income Statement [Abstract]
Net sales	$ 234,138	$ 254,143	$ 716,138	$ 748,036
Cost of products sold	152,041	160,246	470,268	467,513
Gross profit	82,097	93,897	245,870	280,523
Selling expenses	27,348	26,552	82,044	78,400
General and administrative expenses	24,233	26,255	74,043	79,407
Research and development expenses	5,325	6,692	17,593	19,134
Amortization of intangibles	7,501	7,486	22,548	21,871
Operating expenses	64,407	66,985	196,228	198,812
Income from operations	17,690	26,912	49,642	81,711
Interest and debt expense	7,698	9,952	24,285	28,788
Investment (income) loss	(54)	(758)	(873)	(1,212)
Foreign currency exchange (gain) loss	3,128	(1,155)	2,730	1,074
Other (income) expense, net	1,029	5,234	25,512	5,840
Income (loss) before income tax expense (benefit)	5,889	13,639	(2,012)	47,221
Income tax expense (benefit)	1,929	3,911	442	12,405
Net income (loss)	$ 3,960	$ 9,728	$ (2,454)	$ 34,816
Average basic shares outstanding (in shares)	28,631	28,744	28,778	28,711
Average diluted shares outstanding (in shares)	28,888	28,991	28,778	28,979
Basic income (loss) per share (in dollars per share)	$ 0.14	$ 0.34	$ (0.09)	$ 1.21
Diluted income (loss) per share (in dollars per share)	0.14	0.34	(0.09)	1.20
Dividends declared per common share (in dollars per share)	$ 0.07	$ 0.07	$ 0.14	$ 0.14